This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Sola Civil Hospital is a public healthcare facility situated in the Sola area of Ahmedabad, Gujarat, India.[1]
Sola Civil Hospital | |
---|---|
Geography | |
Location | Sola, Ahmedabad, Gujarat, India |
Organisation | |
Care system | Public |
Type | General |
Services | |
Emergency department | Yes |
Links | |
Website | GMERS Sola-Hospital |
Overview
editThe hospital offers a wide range of healthcare services, encompassing general medical care as well as specialized treatments in departments such as cardiology, neurology, orthopedics, pediatrics, and gynecology. Sola Civil Hospital aims to deliver affordable healthcare, with a focus on serving disadvantaged sections of society.[2] [3] [4]
Services and facilities
editThe hospital is equipped with modern medical technology and provides emergency services, outpatient and inpatient care, as well as surgical procedures. It has also conducted clinical trials for Covaxin, the COVID-19 vaccine developed in India.[5]
Community outreach
editThe hospital actively participates in public health initiatives and campaigns for disease prevention. Additionally, it organizes health camps, offering free or subsidized healthcare services to underprivileged communities.[6]
Reference
edit- ^ "Sola Civil's Rs 40-cr 'corporate' makeover". Ahmedabad Mirror. Retrieved 2024-03-22.
- ^ "Razing of Sola Civil building delayed due to internal row". Ahmedabad Mirror. Retrieved 2024-03-22.
- ^ "Ahmedabad: Fire safety gear installation only half done at Sola Civil Hospital". The Times of India. 2020-11-28. ISSN 0971-8257. Retrieved 2024-03-22.
- ^ "Botched up surgery alleged at Sola Civil hospital". The Times of India. 2016-08-09. ISSN 0971-8257. Retrieved 2024-03-22.
- ^ "Ahmedabad: Power outage in Sola Civil Hospital troubles patients, relatives". The Times of India. 2022-06-28. ISSN 0971-8257. Retrieved 2024-03-22.
- ^ "Sola Civil Hospital in Ahmedabad begins Phase-3 trial of Covaxin". The Times of India. 2020-11-27. ISSN 0971-8257. Retrieved 2024-03-22.
See also
edit